Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization

Medicine & Life Sciences

• erbB-2 Genes 100%
• Gene Amplification 84%
• Fluorescence In Situ Hybridization 73%
• In Situ Hybridization 65%
• Prostatic Neoplasms 57%
• Immunohistochemistry 50%
• Prostatic Intraepithelial Neoplasia 29%
• Trastuzumab 24%
• Aneuploidy 22%
• Eligibility Determination 18%
• Fluorescent Antibody Technique 17%
• Monoclonal Antibodies 15%
• Chromosomes, Human, Pair 17 13%
• DNA Probes 12%
• Membranes 12%
• Diploidy 11%
• Prostatectomy 10%
• Neoplasms 9%
• Oncogenes 9%
• Paraffin 9%
• Androgens 9%
• Disease Progression 8%
• Proteins 7%
• Direction compound 7%
• Lymph Nodes 7%
• Clinical Trials 6%
• Staining and Labeling 6%
• Breast Neoplasms 6%
• Neoplasm Metastasis 6%
• Antibodies 5%